Role of ferroptosis in breast cancer: Molecular mechanisms and therapeutic interventions
- 14 May 2025
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 134, 111869
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Henan Province (24B310001)
- Henan University (HUSSYS2024001)
- Science and Technology Department of Henan Province (252102310338, 242102310194)
This publication has 135 references indexed in Scilit:
- HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBCMolecular Carcinogenesis, 2024
- High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBCAdvanced Science, 2024
- Peiminine regulates bone‐fat balance by canonical Wnt/β‐catenin pathway in an ovariectomized rat modelPhytotherapy Research, 2023
- PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunityCancer Communications, 2022
- CDK4/6 inhibitors: A potential therapeutic approach for triple negative breast cancerMedcomm, 2021
- The role of ferroptosis‐related genes for overall survival prediction in breast cancerJournal of Clinical Laboratory Analysis, 2021
- Recent Progress in Ferroptosis Inducers for Cancer TherapyAdvanced Materials, 2019
- SOCS1 is associated with clinical progression and acts as an oncogenic role in triple‐negative breast cancerIUBMB Life, 2018
- Interleukin‐6 contributes to chemoresistance in MDA‐MB‐231 cells via targeting HIF‐1αJournal of Biochemical and Molecular Toxicology, 2018
- Antitumor Agents XLI: Effects of Eupaformosanin on Nucleic Acid, Protein, and Anaerobic and Aerobic Glycolytic Metabolism of Ehrlich Ascites CellsJournal of Pharmaceutical Sciences, 1980